Results 341 to 342 of about 13,086,034 (342)

Phase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia A

Journal of Thrombosis and Haemostasis, 2014
exaly  

[Hemophilia A with inhibitor].

Ryoikibetsu shokogun shirizu, 1999
openaire   +2 more sources